Skip to content

Development and Validation of a Radiologic Immune Quantification System

Development and Validation of a Radiologic Immune Quantification System - IRIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037380
Enrollment
10000
Registered
2025-08-21
Start date
2025-08-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune competence as well as disease progression, treatment response, and complications in patients with various diseases, particularly in oncology and cardiology, but not limited to these.

Interventions

Group 1: Observational Study: Arm 1: Analysis of CT/MRI imaging and routine clinical data (body structures/ organs, body composition, diagnoses, laboratory values, clinical outcomes) without any addit

Sponsors

Universitätsklinikum Frankfurt am Main
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Presence of a clinically indicated CT or MRI examination including imaging of the thorax and/or abdomen or a cardiac CT. For the prospective validation arm additionally: existing venous access and capacity to provide informed consent.

Exclusion criteria

Exclusion criteria: Objection to the use of clinical routine data, missing or incomplete imaging data. For the prospective validation arm additionally: lack of capacity to provide informed consent, no venous access.

Design outcomes

Primary

MeasureTime frame
Development and validation of an interpretable imaging-based immune score based on routine CT/MRI data for the non-invasive assessment of individual immune competence and its correlation with clinical outcomes as well as biological immune parameters.

Countries

Germany

Contacts

Public ContactSimon Bernatz

Universitätsklinikum Frankfurt am Main

bernatz@med.uni-frankfurt.de+49 69 6301 85306

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026